Monitoring antifungal treatment response in neutropenic patient with aspergillosis Clóvis Arns da Cunha, MD Professor at Infectious Diseases Division,
Medical Complications of Renal Transplantation Thitisak Kitthaweesin,MD.
An Introduction to Anti-fungal Pharmacology The following slides were generously supplied by Professor Russell E. Lewis, Pharm.D., BCPS University of Houston.
Latest Developments in the Treatment of Invasive Aspergillosis William J. Steinbach, MD Assistant Professor of Pediatrics, Molecular Genetics, and Microbiology.
Galactomannan testing: lessons from the last decade Claudio Viscoli Professor of Infectious Disease, University of Genova Chief, Division of Infectious.
Getting antifungal drug levels right – why does it matter? David Andes University of Wisconsin.
Clinical failure and its management David W. Denning Director, National Aspergillosis Centre University Hospital South Manchester [Wythenshawe Hospital]
ID Subspeciality Rounds 12/9/08 Dr.Akshra Verma Dr.Janet Jokela.
Consenso micoses pulmonares 2011 ats
When to Consider Neurosurgical Interventions for the Management of Complicated Cryptococcal Meningitis
HIV and Oral Health.doc.doc
Antifungaldrugs
![Clinical failure and its management David W. Denning Director, National Aspergillosis Centre University Hospital South Manchester [Wythenshawe Hospital]](https://static.fdocuments.net/doc/330x215/551796265503463e368b57c0/clinical-failure-and-its-management-david-w-denning-director-national-aspergillosis-centre-university-hospital-south-manchester-wythenshawe-hospital.jpg)
